XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.26.1

Particulars of subsidiaries | 12 Months Ended
--- | ---
Dec. 31, 2025
Disclosure of subsidiaries [abstract] |
Particulars of subsidiaries | Particulars of subsidiaries Particulars of the Company's subsidiaries at the end of the reporting period are as follows:
Name of subsidiary |  | Place of incorporation |  | Issued and fully paid ordinary share |  | Proportion of issued and fully paid ordinary shares held by the Company |  | Principal activity
|  |  |  |  |  | 2025 |  | 2024 |  |
|  |  |  |  |  | % |  | % |  |
Directly held: |  |  |  |  |  |  |  |  |  |
Insighta Limited |  | Hong Kong |  | HKD10,000 |  |  | 100 |  | 100 |  | Biotechnology research and investment holding
Indirectly held: |  |  |  |  |  |  |  |  |  |
明察康健(深圳)科技有限责任公司 |  | The PRC |  | CNY10,000,000 |  |  | 100 |  | 100 |  | Dormant
得易健康产业(深圳)有限责任公司 |  | The PRC |  | CNY100,000 |  |  | 100 |  | 100 |  | Biotechnology research
得易健康生物(广州)有限公司 |  | The PRC |  | CNY20,000,000 |  |  | 100 |  | 100 |  | Biotechnology research

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 75 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph B4 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 75 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration